Solarea Bio, and Hebrew SeniorLife have teamed up for a competitive research grant received from the U.S. National Academy of Medicine’s Health Longevity Initiative extensively focusing on Mycobiome.
Researchers from the New England based Hebrew SeniorLife affiliated with Harvard Medical School suggest a significant rise in age-related diseases. Diseases including cardiovascular or Alzheimer’s wherein age plays a crucial role are on the spike. Chronic low-grade inflammation if the focal point of the age-related diseases often known as inflammaging. Through recent studies, it has been evident that the gut microbiome acts as a key regulator stimulating the inflammaging process. Microbiome directly impacts the development and functioning of the immune system.
The researchers along with Solarea Bio hypothesize the mycobiome capabilities. Mycobiome, a part of microbiome refers to collection of the fungi present. Mycobiome could potentially provide an untapped reserve of probiotic fungi capable of countering inflammaging. The team will sequence a subset of massive fungal collection identifying the fungi with potential probiotic.